Xenon Pharmaceuticals Inc (XENE NASDAQ) stock market data APIs
$38.5051
-0.2(-0.5%)
as of November 7, 2025
Try our APIs with
free plan!
Xenon Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
Prev. Close
38.5051
Open
38.3029
High
38.0722
Low
37.5673
52 wk Range
26.74-45.45
Market Cap
2 956 M
Shares Outstanding
77 275 K
Revenue
7 500 K
EPS
-1.15
Beta
1.034
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Xenon Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Xenon Pharmaceuticals Inc data using free add-ons & libraries
Get Xenon Pharmaceuticals Inc Fundamental Data
Xenon Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 7 500 K
- EBITDA: -338 182 016
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: -1.15
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Xenon Pharmaceuticals Inc News
New
Xenon Pharmaceuticals (XENE): Losses Widen 37% Annually, Challenging Bullish Revenue Growth Expectations
Xenon Pharmaceuticals (XENE) posted another year of heavy losses, with net profit margins remaining deeply negative and losses rising at an average annual rate of 37% over the last five years. Even as...
Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus
Xenon Pharmaceuticals XENE reported a loss of $1.15 per share for the third quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of $1.16. The company had incurred a loss of 81 cents ...
Xenon Pharmaceuticals Inc (XENE) Q3 2025 Earnings Call Highlights: Strong Financial Position ...
This article first appeared on GuruFocus. Cash, Cash Equivalents, and Marketable Securities: $555.3 million as of September 30, 2025, compared to $754.4 million as of December 31, 2024. Phase 3 XTOL2...
Xenon Pharmaceuticals: Q3 Earnings Snapshot
BURNABY, British Columbia (AP) — BURNABY, British Columbia (AP) — Xenon Pharmaceuticals Inc. (XENE) on Monday reported a loss of $90.9 million in its third quarter. On a per-share basis, the Burn...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
